OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Radiotherapy for glioblastoma: clinical issues and nanotechnology strategies
Ruiqi Li, Haihong Wang, Qing Liang, et al.
Biomaterials Science (2021) Vol. 10, Iss. 4, pp. 892-908
Closed Access | Times Cited: 37
Ruiqi Li, Haihong Wang, Qing Liang, et al.
Biomaterials Science (2021) Vol. 10, Iss. 4, pp. 892-908
Closed Access | Times Cited: 37
Showing 1-25 of 37 citing articles:
Recent Progress in Anti‐Tumor Nanodrugs Based on Tumor Microenvironment Redox Regulation
Lan Yao, Zhu Xiang, Yunyi Shan, et al.
Small (2024) Vol. 20, Iss. 25
Closed Access | Times Cited: 20
Lan Yao, Zhu Xiang, Yunyi Shan, et al.
Small (2024) Vol. 20, Iss. 25
Closed Access | Times Cited: 20
Nanoparticles Hitchhike on Monocytes for Glioblastoma Treatment after Low-Dose Radiotherapy
Jing Kuang, Zhi‐Yong Rao, Diwei Zheng, et al.
ACS Nano (2023) Vol. 17, Iss. 14, pp. 13333-13347
Closed Access | Times Cited: 41
Jing Kuang, Zhi‐Yong Rao, Diwei Zheng, et al.
ACS Nano (2023) Vol. 17, Iss. 14, pp. 13333-13347
Closed Access | Times Cited: 41
Highlighted Advances in Therapies for Difficult-To-Treat Brain Tumours Such as Glioblastoma
Nuno Cruz, Manuel Herculano-Carvalho, Diogo Roque, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 928-928
Open Access | Times Cited: 31
Nuno Cruz, Manuel Herculano-Carvalho, Diogo Roque, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 928-928
Open Access | Times Cited: 31
METTL3-mediated m6A modification of LINC00839 maintains glioma stem cells and radiation resistance by activating Wnt/β-catenin signaling
Jianxing Yin, Fangshu Ding, Zhangchun Cheng, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 7
Open Access | Times Cited: 31
Jianxing Yin, Fangshu Ding, Zhangchun Cheng, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 7
Open Access | Times Cited: 31
Recent Advances in Biomimetic Strategies for the Immunotherapy of Glioblastoma
Haoyu You, Shuo Geng, Shangkuo Li, et al.
Biomaterials (2024) Vol. 311, pp. 122694-122694
Closed Access | Times Cited: 10
Haoyu You, Shuo Geng, Shangkuo Li, et al.
Biomaterials (2024) Vol. 311, pp. 122694-122694
Closed Access | Times Cited: 10
Nanoparticle-based Drug Delivery Systems to Modulate Tumor Immune Response for Glioblastoma Treatment
Yan-Juan Xiong, Maoyuan Sun, Qingzhu Yang, et al.
Acta Biomaterialia (2025)
Closed Access | Times Cited: 1
Yan-Juan Xiong, Maoyuan Sun, Qingzhu Yang, et al.
Acta Biomaterialia (2025)
Closed Access | Times Cited: 1
Mn-MOF catalyzed multi-site atom transfer radical polymerization electrochemical sensing of miRNA-21
Jiao Wang, Jingliang Liu, Lianzhi Li, et al.
Microchimica Acta (2023) Vol. 190, Iss. 8
Closed Access | Times Cited: 12
Jiao Wang, Jingliang Liu, Lianzhi Li, et al.
Microchimica Acta (2023) Vol. 190, Iss. 8
Closed Access | Times Cited: 12
Deeper insight into ferroptosis: association with Alzheimer’s, Parkinson’s disease, and brain tumors and their possible treatment by nanomaterials induced ferroptosis
Virendra Kumar Yadav, Nisha Choudhary, Amel Gacem, et al.
Redox Report (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 12
Virendra Kumar Yadav, Nisha Choudhary, Amel Gacem, et al.
Redox Report (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 12
USP19 regulates DNA methylation damage repair and confers temozolomide resistance through MGMT stabilization
Jiaqi Liu, Kaikai Wang, Qian Zhu, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 4
Open Access | Times Cited: 4
Jiaqi Liu, Kaikai Wang, Qian Zhu, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 4
Open Access | Times Cited: 4
CD9- and CD81-positive extracellular vesicles provide a marker to monitor glioblastoma cell response to photon-based and proton-based radiotherapy
Sara Jennrich, Martin Pelzer, Tobias Tertel, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17
Sara Jennrich, Martin Pelzer, Tobias Tertel, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17
Recent Progress in Fluorescent Probes for Real-Time Monitoring of Glioblastoma
Amita Mondal, Jisoo Kang, Dokyoung Kim
ACS Applied Bio Materials (2023) Vol. 6, Iss. 9, pp. 3484-3503
Closed Access | Times Cited: 10
Amita Mondal, Jisoo Kang, Dokyoung Kim
ACS Applied Bio Materials (2023) Vol. 6, Iss. 9, pp. 3484-3503
Closed Access | Times Cited: 10
Modern insights of nanotheranostics in the glioblastoma: An updated review
Roopkumar Sangubotla, Kumar Shiva Gubbiyappa, Rajakumari Devarapogu, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 3, pp. 167653-167653
Closed Access
Roopkumar Sangubotla, Kumar Shiva Gubbiyappa, Rajakumari Devarapogu, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 3, pp. 167653-167653
Closed Access
Decoding the Role of Kinesin Superfamily Proteins in Glioma Progression
Mohamed J. Saadh, Zahraa Sabah Ghnim, Morug Salih Mahdi, et al.
Journal of Molecular Neuroscience (2025) Vol. 75, Iss. 1
Closed Access
Mohamed J. Saadh, Zahraa Sabah Ghnim, Morug Salih Mahdi, et al.
Journal of Molecular Neuroscience (2025) Vol. 75, Iss. 1
Closed Access
Why Do Glioblastoma Treatments Fail?
Alen Rončević, Nenad Koruga, Anamarija Soldo Koruga, et al.
Future Pharmacology (2025) Vol. 5, Iss. 1, pp. 7-7
Open Access
Alen Rončević, Nenad Koruga, Anamarija Soldo Koruga, et al.
Future Pharmacology (2025) Vol. 5, Iss. 1, pp. 7-7
Open Access
Variability in radiotherapy outcomes across cancer types: a comparative study of glioblastoma multiforme and low-grade gliomas
Alexander Veviorskiy, Garik V. Mkrtchyan, А. Н. Осипов, et al.
Aging (2025)
Open Access
Alexander Veviorskiy, Garik V. Mkrtchyan, А. Н. Осипов, et al.
Aging (2025)
Open Access
Lipid nanoparticles for treatment of glioblastoma multiforme: current status of research and clinical translation
Mugdha Kulkarni, Karthik Nadendla, Ananth Pai, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106891-106891
Open Access
Mugdha Kulkarni, Karthik Nadendla, Ananth Pai, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106891-106891
Open Access
Impact of KIF4A on Cancer Stem Cells and EMT in Lung Cancer and Glioma
Yeon-Jee Kahm, In‐Gyu Kim, Uhee Jung, et al.
Cancers (2023) Vol. 15, Iss. 23, pp. 5523-5523
Open Access | Times Cited: 9
Yeon-Jee Kahm, In‐Gyu Kim, Uhee Jung, et al.
Cancers (2023) Vol. 15, Iss. 23, pp. 5523-5523
Open Access | Times Cited: 9
Advanced tumor electric fields therapy: A review of innovative research and development and prospect of application in glioblastoma
Jinxin Lan, Yuyang Liu, Junyi Chen, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 5
Open Access | Times Cited: 3
Jinxin Lan, Yuyang Liu, Junyi Chen, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 5
Open Access | Times Cited: 3
The Molecular and Cellular Strategies of Glioblastoma and Non-Small-Cell Lung Cancer Cells Conferring Radioresistance
Lina Alhaddad, А. Н. Осипов, Sergey Leonov
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13577-13577
Open Access | Times Cited: 13
Lina Alhaddad, А. Н. Осипов, Sergey Leonov
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13577-13577
Open Access | Times Cited: 13
Reactive oxidative species (ROS)-based nanomedicine for BBB crossing and glioma treatment: current status and future directions
Dandan Wu, Xue-Hui Chen, Shuqiu Zhou, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Dandan Wu, Xue-Hui Chen, Shuqiu Zhou, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Chlorin e6-modified iron oxide nanoparticles for photothermal-photodynamic ablation of glioblastoma cells
Hongqing Yao, Jianying Zhou
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 7
Hongqing Yao, Jianying Zhou
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 7
Knockdown of ATRX enhances radiosensitivity in glioblastoma
Yue Zhao, Yifei Chen, Ruo-Yu Liu, et al.
Chinese Neurosurgical Journal (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Yue Zhao, Yifei Chen, Ruo-Yu Liu, et al.
Chinese Neurosurgical Journal (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Development of an Injectable Hydrogel for Histotripsy Ablation Toward Future Glioblastoma Therapy Applications
Zerin Mahzabin Khan, Junru Zhang, Jessica M. Gannon, et al.
Annals of Biomedical Engineering (2024)
Open Access | Times Cited: 2
Zerin Mahzabin Khan, Junru Zhang, Jessica M. Gannon, et al.
Annals of Biomedical Engineering (2024)
Open Access | Times Cited: 2
Glioblastoma multiforme: Diagnosis, treatment, and invasion
Jiawei Li, Lili Feng, Ying‐Mei Lu
Journal of Biomedical Research (2022) Vol. 37, Iss. 1, pp. 47-47
Open Access | Times Cited: 11
Jiawei Li, Lili Feng, Ying‐Mei Lu
Journal of Biomedical Research (2022) Vol. 37, Iss. 1, pp. 47-47
Open Access | Times Cited: 11
Comprehensive analysis of the prognosis and immune infiltrates for the BET protein family reveals the significance of BRD4 in glioblastoma multiforme
Yintao Ye, Wei Zhong, Junqiang Qian, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 6
Yintao Ye, Wei Zhong, Junqiang Qian, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 6
